AlzBiomarker
Alzheimer's Disease vs Control: neurogranin (CSF)
Meta-analysis Results: In recent years, studies have found the synaptic protein neurogranin to be consistently higher in people with Alzheimer’s disease compared with controls (effect size = 1.937, p <0.0001). Although the number of studies available for meta-analysis is still relatively small, the effect has been observed with different methods/assays.

